Scientech Research LLC Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Scientech Research LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 44.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,554 shares of the medical equipment provider's stock after selling 2,053 shares during the period. Scientech Research LLC's holdings in Intuitive Surgical were worth $1,333,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Royal Bank of Canada dropped their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Bernstein Bank lifted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. Evercore ISI decreased their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Finally, Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded down $4.47 during trading hours on Tuesday, reaching $557.16. The company's stock had a trading volume of 1,233,924 shares, compared to its average volume of 1,644,792. The firm has a 50 day moving average price of $506.50 and a 200-day moving average price of $537.23. Intuitive Surgical, Inc. has a one year low of $396.15 and a one year high of $616.00. The stock has a market cap of $199.70 billion, a P/E ratio of 86.92, a P/E/G ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the firm posted $1.50 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 32,700 shares of company stock valued at $16,865,621. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.